Cancer
Researchers at Yale University School of Medicine have investigated the diagnostic outcomes of MRI-ultrasound fusion targeted biopsy in detecting clinically significant prostate cancer. The study aimed to evaluate the effectiveness of using microUS technology and conventional ultrasound in detecting cancers using targeted biopsy. The researchers analyzed a matched sample of
Cancer
Ryne Sandberg, a legendary figure in Chicago Cubs history and a member of the Major League Baseball Hall of Fame, has passed away at the age of 65 following a battle with metastatic prostate cancer. Sandberg's journey with the disease was marked by periods of hope and then
Cancer
A 75-year-old retired primary school teacher, Jean Quinn, has completed a 373-mile bike ride from Colchester to Devon for Prostate Cancer UK. The ride, which took place in late July, is a testament to Quinn's determination and love for cycling. As a volunteer with Sustrans, a charity that
Cancer
Liquid biopsy-based multi-cancer early detection (MCED) has been identified as a promising approach to revolutionize cancer control, offering a potential solution to the limitations of current cancer screening methods. Despite several MCED tests reaching clinical trial phases, none have yet been approved for clinical use, highlighting uncertainties regarding their efficacy
Cancer
Data from Vienna, Austria, indicate that due to increasing use of imaging and lung cancer screening programs, the rate of detected pulmonary nodules has steadily increased over the past decade. According to research from Medical University of Vienna, the diagnosis and management of pulmonary nodules remain challenging. The study highlights
Cancer
In a breakthrough study published in the Proceedings of the National Academy of Sciences, Northwestern University biomedical engineers have discovered a new approach to cancer treatment that doubles the effectiveness of chemotherapy in animal experiments. Led by Vadim Backman, the team developed a strategy that prevents cancer cells from evolving
Cancer
The Reducing Hereditary Cancer Act, a bipartisan bill re-introduced by U.S. Reps. Debbie Wasserman Schultz (FL-25), Mariannette Miller-Meeks (IA-02), Kim Schrier (WA-08), and Vern Buchanan (FL-13), seeks to expand access to lifesaving genetic testing for Medicare beneficiaries. Currently, Medicare only covers genetic testing for beneficiaries already diagnosed with cancer,
Cancer
Researchers at Tarbiat Modares University in Iran have made a significant discovery in the field of cancer treatment. The team, led by Shokouh Rezaei, has developed folate-functionalized zein-PEI nanoparticles that show enhanced biocompatibility and targetability. These nanoparticles have been designed to deliver targeted cancer therapy with improved stability and reduced
Cancer
The Renal Cancer pipeline landscape is thriving, with over 75 companies developing more than 80 pipeline therapies for the treatment of renal cell carcinoma (RCC). The pipeline is rich with innovative assets, including monoclonal antibodies, small molecules, and gene therapies, aimed at addressing the unmet needs of patients with this
Cancer
Research conducted by Chongqing University Cancer Hospital has shed light on the significant risk of thromboembolic events (TEEs) associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs). The study, published in Scientific Reports, analyzed data from the FAERS database and found that the incidence of TEEs was 2.
Cancer
The Endometrial Cancer market is experiencing significant growth due to the increasing prevalence and awareness of the disease. Emerging therapies and novel treatment strategies are also contributing to the market's expansion. According to a recent report by DelveInsight, the Endometrial Cancer market is expected to surge, with a
Cancer
Historical discriminatory policies, such as residential redlining, and current socioeconomic status can significantly impact gastrointestinal (GI) cancer care, resulting in disparities in diagnosis and treatment. A recent study conducted by researchers from Ohio State University investigated how evolving neighborhood characteristics affect the diagnosis and treatment of GI cancer. The findings
